Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30882137.
- Also identified by DOI 10.1093/cid/ciz223 and PMC identifier 7320076.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a multicenter, observational, propensity-score-weighted cohort of 249 adults with uncomplicated Pseudomonas aeruginosa bacteremia, patients receiving short-course (median, 9 days; interquartile range [IQR], 8-10) therapy had a similar odds of recurrent infection or death within 30 days as those receiving longer courses (median, 16 days; IQR, 14-17).
Medical subject headings
- Bacteremia
- Piperacillin, Tazobactam Drug Combination
- Pseudomonas aeruginosa